MIMEDX GROUP, INC.MDXG

Market cap
$1.1B
P/E ratio
Dec 31,
2011
Dec 31,
2012
Dec 31,
2013
Dec 31,
2014
Dec 31,
2015
Dec 31,
2016
Dec 31,
2018
Dec 31,
2019
Dec 31,
2020
Dec 31,
2021
Dec 31,
2022
Dec 31,
2023
Dec 31,
2024
Net income (loss) from continuing operations-----------6742
Share-based compensation12611171815121515131717
Deferred income tax provision-----------38-12
Shares received in settlement of litigation------------9
Amortization of intangible assets------------4
Depreciation446,502465,367637,2461236764332
Loss on extinguishment of debt---------8----1
Non-cash lease expenses----------111
Credit loss expense----------311
Other------------1
Accounts receivable168112711-11356123
Inventory253,9422857,9921237-711282
Prepaid expenses-----25-0-1130-1
Other assets--96,657-70,000-------0-21
Accounts payable--81,112113-47-60-011-1
Accrued compensation-----------23
Accrued expenses-3352,88112616-02-212-2-1
Other liabilities16,383-12,731-28,9691-111-3-2-10-0-1
Net cash flows provided by (used in) operating activities of continuing operations-----------3567
Net cash flows used in operating activities of discontinued operations------------8-1
Net cash flows provided by (used in) operating activities-6,664,771-3,384,831-285,47717192636-39-30-2-182766
Purchases of equipment486,091582,931236692432-2
Cash paid for acquisitions------------8
Other------------0
Net cash flows used in investing activities-702,508-582,931-3,025,414-12-1-12-91-5-3-3-2-10
Proceeds from Long-Term Lines of Credit------------30
Proceeds from Issuance of Secured Debt------------20
Prepayment premium on Hayfin term loan--------1---1
Deferred financing cost----10-73---1
Repayment of Hayfin term loan------------50
Repayment of Citizens Revolving Credit Facility------------30
Principal Payments of Secured Debt-------------1
Proceeds from Stock Options Exercised295,753122534001111
Stock repurchased for tax withholdings on vesting of restricted stock-----151251-3
Repurchase of Series B Preferred Shares-----------10-
Other-------------0
Net cash flows used in financing activities10741-2-36-8-96362-3-1-9-34
Net change in cash-------2427-9-211622